Identify the Prognostic and Immune Profile of VSIR in the Tumor Microenvironment: A Pan-Cancer Analysis
Yuanyuan Liu(Central South University), Quan Cheng(Central South University), Tubao Yang(Central South University), Wantao Wu(Central South University), Peng Luo(Zhujiang Hospital), Zhipeng Wen(Central South University), Nan Zhang(Huazhong University of Science and Technology), Zeyu Wang(Anhui University), Xun Zhang(Zaozhuang University), Hao Zhang(Northwestern Polytechnical University), Jian Zhang(Zhujiang Hospital), Jingwei Zhang(Sichuan University), Jing Yu(Central South University), Zaoqu Liu(Chinese Academy of Medical Sciences & Peking Union Medical College), Ziyu Dai(Central South University)
Cited by 20
Related Papers
NF-κB in biology and targeted therapy: new insights and translational implications
|Signal Transduction and Targeted Therapy|2024|1.6k
Glioma targeted therapy: insight into future of molecular approaches
|Molecular Cancer|2022|727
PLGA-based biodegradable microspheres in drug delivery: recent advances in research and application
|Drug Delivery|2021|578
PARP inhibitor resistance: the underlying mechanisms and clinical implications
|Molecular Cancer|2020|548
Regulatory mechanisms of immune checkpoints PD-L1 and CTLA-4 in cancer
|Journal of Experimental & Clinical Cancer Research|2021|535